Please join Amgen and Regencor co-founder, Pilar Ruiz-Lozano, for the next Founders-At-Work Speaker Series where entrepreneurs connect, share their stories and talk about science!
Speaker:
As a member of the Faculty at Stanford School of Medicine, Dr. Ruiz-Lozano pioneered the development of tissue engineering and epicardial biology to treat heart disease. She led the discovery of the cardiac regenerative properties of recombinant human FSTL1 and the development of delivery modalities that are now licensed by Regencor, Inc.